A source credits Ezequiel Munoz-Gonzalez, MD, as a coauthor of an article about percutaneous coronary intervention in patients with cancer. The surname differs from the supplied person name, so identity is not certain.[5]
2019
Listed as Ezequiel Munoz, MD for the case presentation “Catch Me if You Can.”
As of 2025 · Last known relationship
Ezequiel Munoz is an interventional cardiologist whose training spans Venezuela, Chicago, and Duke, with clinical and academic interests in complex structural and coronary interventions. He completed medical school at Central University of Venezuela in 2014 and an Internal Medicine residency at Cook County Health and Hospitals System from 2016 to 2019. He was listed in Duke’s 2023-2024 Cardiovascular Disease Fellowship alumni cohort, associated with Ascension St. Vincent in Indianapolis. A public physician profile identifies him as a Carmel, Indiana cardiologist affiliated with Riverview Health and specializing in interventional cardiology, with American Board of Internal Medicine certifications listed in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology. His documented scholarly work includes PCI and valve replacement in patients with cancer and valve-in-valve TAVR.
Each topic is linked to its supporting source in Sources.
Training includes Listed as Ezequiel Munoz, MD for the case presentation “Catch Me if You Can.”, Listed as an alumnus of Duke's Cardiovascular Disease Fellowship in the 2023-2024 cohort., Completed an Internal Medicine residency at Cook County Health and Hospitals System., and Completed medical school at Central University of Venezuela., plus 6 more records.
Explore education and trainingAs of 2025
As of 2024
As of 2019
As of 2014
A source credits Ezequiel Munoz-Gonzalez, MD, as a coauthor of an article about percutaneous coronary intervention in patients with cancer. The surname differs from the supplied person name, so identity is not certain.[5]
2019
Coauthored a JACC: Case Reports article concerning single-ventricle anatomy and valve-in-valve TAVR.[2]
Presented an abstract or poster comparing in-hospital outcomes of transcatheter and surgical aortic valve replacement in patients with cancer at the 2019 ACC Scientific Session.[2]
2019